Axon Therapies is a private MedTech company developing minimally invasive therapies that address the root causes of heart failure. Its lead innovation, SAVM using the Satera™ Ablation System, enables targeted ablation of the overactive sympathetic nervous system without the need for an implant.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/26/25 | $32,000,000 | Series A |
CD Capital Deerfield Management Company, L.P. Earlybird  KOFA Healthcare Sante Ventures | undisclosed |
